These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16752714)

  • 1. The price of progress: destination left ventricular assist device therapy for terminal heart failure.
    Selzman CH; Oberlander J
    N C Med J; 2006; 67(2):116-7. PubMed ID: 16752714
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destination therapy: does progress depend on left ventricular assist device development?
    von Bayern MP; Cadeiras M; Deng MC
    Heart Fail Clin; 2007 Jul; 3(3):349-67. PubMed ID: 17723941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upstream palliative care for the patient with a left ventricular assist device as destination therapy.
    Byram EK
    Dimens Crit Care Nurs; 2012; 31(1):18-24. PubMed ID: 22156807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HeartMate II left ventricular assist device: a new device for advanced heart failure.
    Delgado R; Bergheim M
    Expert Rev Med Devices; 2005 Sep; 2(5):529-32. PubMed ID: 16293063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Left ventricular assist device - unexpected benefits for the failing heart].
    Pasierski T; Buksińska-Lisik M
    Kardiol Pol; 2008 Jun; 66(6):678-83. PubMed ID: 18626838
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data.
    Morley D; Litwak K; Ferber P; Spence P; Dowling R; Meyns B; Griffith B; Burkhoff D
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):21-8. PubMed ID: 17198776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
    Soderlund KA; Chivukula RR; Russell SD; Conte JV; Mudd JO; Halushka MK
    Cardiovasc Pathol; 2009; 18(4):217-22. PubMed ID: 18706833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
    Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
    J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device-induced molecular changes in the failing myocardium.
    Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
    Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.
    Simsir SA; Lin SS; Blue LJ; Gockerman JP; Russell SD; Milano CA
    Ann Thorac Surg; 2005 Aug; 80(2):717-9. PubMed ID: 16039240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing the post-left ventricular assist device patient.
    Klodell CT; Staples ED; Aranda JM; Schofield RS; Hill JA; Pauly DF; Beaver TM
    Congest Heart Fail; 2006; 12(1):41-5. PubMed ID: 16470091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective bridging to recovery after repair: the surgical approach to ventricular reverse remodeling.
    Pitsis AA; Visouli AN; Ninios V; Bougioukas G; Filippatos G; Kremastinos D; Burkhoff D; Long JW
    Artif Organs; 2008 Sep; 32(9):730-5. PubMed ID: 18684205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional mitral stenosis: a rare complication of the Impella assist device.
    Toggweiler S; Jamshidi P; Erne P
    Eur J Echocardiogr; 2008 May; 9(3):412-3. PubMed ID: 18490340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure.
    Roberts WC; Vowels TJ; Ko JM; Capehart JE; Hall SA
    Am J Cardiol; 2009 Jan; 103(1):110-4. PubMed ID: 19101239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient selection for left ventricular assist devices.
    Khazanie P; Rogers JG
    Congest Heart Fail; 2011; 17(5):227-34. PubMed ID: 21906247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.